0.2294
price down icon2.51%   -0.0059
after-market アフターアワーズ: .24 0.0106 +4.62%
loading
前日終値:
$0.2353
開ける:
$0.23
24時間の取引高:
584.29K
Relative Volume:
0.30
時価総額:
$1.16M
収益:
-
当期純損益:
$-11.53M
株価収益率:
-0.0476
EPS:
-4.82
ネットキャッシュフロー:
$-11.12M
1週間 パフォーマンス:
+3.99%
1か月 パフォーマンス:
-41.03%
6か月 パフォーマンス:
-83.01%
1年 パフォーマンス:
-89.08%
1日の値動き範囲:
Value
$0.22
$0.2399
1週間の範囲:
Value
$0.2039
$0.25
52週間の値動き範囲:
Value
$0.15
$3.10

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
名前
Processa Pharmaceuticals Inc
Name
セクター
Healthcare (1153)
Name
電話
443-776-3133
Name
住所
7380 COCA COLA DRIVE, HANOVER
Name
職員
13
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
PCSA's Discussions on Twitter

PCSA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.2294 1.16M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.50 126.09B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 64.01B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.51 36.63B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.19 30.64B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.77 27.24B 3.81B -644.79M -669.77M -6.24

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-04-25 開始されました H.C. Wainwright Buy

Processa Pharmaceuticals Inc (PCSA) 最新ニュース

pulisher
Apr 24, 2025

Processa Pharmaceuticals Inc [PCSA] Shares Rise 8.43 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN

Apr 24, 2025
pulisher
Apr 22, 2025

Processa Pharmaceuticals Inc (PCSA) can make a big difference with a little luck - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

A Closer Look at Processa Pharmaceuticals Inc (PCSA) Stock Gains - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Recent Insider Activity Suggests Potential Gains for Processa Pharmaceuticals Inc (PCSA) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 15, 2025

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Project Optimus: Processa Unveils New Approach for Rare Disease Treatment Success - Stock Titan

Apr 15, 2025
pulisher
Apr 12, 2025

Data-Based Insights About Processa Pharmaceuticals Inc (PCSA) - stocksregister.com

Apr 12, 2025
pulisher
Apr 11, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.22 - Investing.com

Apr 11, 2025
pulisher
Apr 10, 2025

PCSA Stock Sees Decline of Approximately -11.67% in Last Five Days - knoxdaily.com

Apr 10, 2025
pulisher
Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com India

Apr 02, 2025
pulisher
Mar 28, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com

Mar 25, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals Inc. (PCSA) reports earnings - qz.com

Mar 20, 2025
pulisher
Mar 18, 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India

Mar 13, 2025
pulisher
Mar 11, 2025

Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart

Mar 11, 2025
pulisher
Mar 04, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com

Mar 04, 2025
pulisher
Feb 28, 2025

Processa Pharma Stock Price, Quotes and Forecasts - Benzinga

Feb 28, 2025
pulisher
Feb 21, 2025

The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl

Feb 21, 2025
pulisher
Feb 21, 2025

Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions

Feb 21, 2025
pulisher
Feb 21, 2025

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025
pulisher
Feb 20, 2025

10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 20, 2025
pulisher
Feb 13, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria

Feb 13, 2025
pulisher
Feb 11, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price - Investing.com

Feb 10, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater

Feb 10, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025
pulisher
Feb 03, 2025

Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex

Feb 03, 2025
pulisher
Jan 31, 2025

Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Jan 31, 2025
pulisher
Jan 30, 2025

Processa Pharmaceuticals Raises $5M in Public Offering - TipRanks

Jan 30, 2025
pulisher
Jan 30, 2025

Processa CEO Doubles Down: Purchases Shares at 30% Premium in $5M Strategic Raise - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Processa Pharmaceuticals director David Young buys $99,288 in stock - Investing.com India

Jan 30, 2025
pulisher
Jan 30, 2025

Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 30, 2025

Processa Pharmaceuticals Inc (PCSA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.79
price up icon 0.78%
$71.40
price up icon 2.20%
$32.71
price up icon 0.52%
$23.62
price down icon 2.03%
$104.00
price up icon 0.00%
biotechnology ONC
$249.77
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):